CPhI Worldwide 2013: Video Highlights of the Biggest Pharma Show

AsiaNet 55090

AMSTERDAM, Nov. 21, 2013 /PRN=KYODO JBN/ --

    - CPhI Worldwide 2013 hosted more than 34,000 global pharma professionals

with expanded content and first Annual Report

    - This year sees strong growth in APIs, biopharma, natural extracts,

packaging and finished dosage with a highlight on innovation

    CPhI Worldwide [http://www.cphi.com], organised by UBM Live, celebrates the

closing of its most successful show to date with pre-audit figures estimating

more than 34,000 attendees and 2,200 exhibitors. Held in Frankfurt, the show

hosted senior-level decision makers and key players from 140+ countries

representing every step of the pharmaceutical supply chain from drug discovery

to finished dosage.

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    To view the Multimedia News Release, please click:

    http://www.multivu.com/mnr/63503-UBM-live-cphl-worldwide

    On Monday, CPhI Conferences hosted the Pre-Connect with six modules on

themes including drug delivery systems and biosimilars. The conference featured

senior executives and influential industry speakers from Bayer, Novartis and

Wockhardt, who leveraged their expertise and insight to educate the industry.

Throughout the week, free content was available in the exhibition with sessions

covering Ingredients, Contract Services, Packaging, Animal Health, Biopharma

and Natural Extracts, Innovation Tours on biopharma and packaging, and Lunch

Briefings on emerging markets of India and Brazil.

    With four different exhibitions in one (CPhI, P-MEC, InnoPack and ICSE) the

event has become the world's melting pot and key point of the year to complete

new deals, see innovative technologies and meet potential partners - attendees

say it's invaluable to the industry. This year's event held a record of 17

global pavilions to highlight different countries from each continent -

including China, India, USA and Brazil amongst others.

    The winners of the 2013 CPhI Pharma Awards were announced, honouring

innovation across three categories (Best Innovation in Formulation, Packaging

and Process Development) which went to Camurus, E-Pharma Trento and API

Corporation, respectively.

    Another major addition to this year's show was the introduction of CPhI

Pharma Evolution - a new community website launched in February to help

professionals from the pharma industry to share advice from their peers on

best-practices and regulatory changes across the pharmaceutical ingredient and

contract manufacturing space. The site features a wealth of stories covering

the huge amounts of activity across all four days of the show, including news

on all the major initiatives and company news announced. For more information,

please visit: http://www.pharmevolution.com

    CPhI Worldwide and CPhI Pharma Evolution were pleased to release its first

Annual Report during the event. Written by a panel of industry experts, the

report highlighted key trends including QbD, PAT and six sigma in a series of

forward-looking articles.

    Chris Kilbee, Group Director of CPhI, commented: "This year's event has

been a great success with exhibitors reporting quality meetings and promising

business opportunities coming out of the event. We're pleased to expand our

content offering this year withseminars, innovation tours and the release of

the first Annual Report. As the pharmaceutical market continues to grow and

expand, CPhI will adapt and evolve to deliver industry insights and continue to

provide the best platform for developing contacts as the event returns to Paris

for its 25th editionfrom 7-9 October 2014."

    Notes to editors

    About CPhI Pharma Evolution annual report and expert industry panel

    Earlier this year, CPhI launched a major new initiative with the

introduction of its annual report published in cooperation with Pharma

Evolution - written by a panel of world-leading experts across the

pharmaceutical supply chain.

    The vision was to harness the power of CPhI's independent position within

the industry so that it could produce unbiased analysis of the global

pharmaceutical industry and help bring different perspectives together.

    The annual report utilises expert in-depth essays, looking at future

contingencies. Experts were given carte blanche to evaluate current industry

practices and examine the future implications for the industry.

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America co-located with ICSE for

contract services, P-MEC for machinery, equipment & technology, InnoPack for

pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer

& supplier directory at CPhI-Online.com and hosts a global community with news

and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI

and P-MEC India (3-5 December, 2013 at the Bombay Exhibition Centre in Mumbai);

CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI

Russia and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC and

Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI Istanbul

(4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld

China (26-28 June, 2014 at SNIEC, Shanghai, China), CPhI South America (5-7

August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI Worldwide, ICSE,

P-MEC Europe and InnoPack (7-9 October, 2014 at Paris Nord Villepintei, Paris-

France)

    About CPhI Pharma Evolution

    CPhI Pharma Evolution (http://www.pharmaevolution.com) launched in February

2013 as a global online community where professionals from across the

pharmaceutical manufacturing sector can talk with their peers and share

best-practices and regulatory updates across the pharmaceutical ingredient and

contract manufacturing space. Pharma Evolution is the new go-to community for

industry professionals to exchange thoughts and network on key areas including:

formulation, APIs, excipients, drug delivery, R&D, manufacturing and quality,

packaging and anti-counterfeiting, regulatory compliance, and outsourcing and

supply chain management. Pharma Evolution was created as an extension of CPhI's

global events business as a forum and resource for pharmaceutical executives to

employ 365 days a year. Pharma Evolution is published by CPhI and UBM DeusM

(http://www.deusm.com), the marketing services division of UBM specializing in

building and operating highly engaged communities of qualified users within

specialist B2B markets, using a strategy of best-practices focused on content

and technology.

    About UBM Live

    UBM Live connects people and creates opportunities for companies across

five continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis

    De Facto Communications

    T: +44(0)207-203-6745 / 6740

    E: a.heeley@defacto.com / t.jervis@defacto.com

    http://www.multivu.com/mnr/63503-UBM-live-cphl-worldwide

    SOURCE: UBM Live